Eagle Meds Services
QELBREE (viloxazine hydrochloride)
Available to sourceHuman Prescription DrugNeurological & Psychiatric

QELBREE (viloxazine hydrochloride)

150 mg/1 · Extended-Release Capsule
By Supernus Pharmaceuticals, Inc
NDC
17772-132
Route
Oral
Therapeutic class
Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor , Norepinephrine Uptake Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-07)NDC 17772-132-07Available to order
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-30)NDC 17772-132-30Available to order
  • 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-60)NDC 17772-132-60Available to order
  • 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-90)NDC 17772-132-90Available to order
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-132-01)NDC 17772-132-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
QELBREE (viloxazine hydrochloride)
NDC 17772-132